Introduction
============

Excimer laser refractive surgery, based on the stromal photoablation of the cornea, is currently the most popular refractive surgery procedure. The concept of generating a free intrastromal lenticule between two photodisruption planes and its mechanical removal for refractive correction was introduced by Ito et al in 1996.[@b1-opth-7-1041] Early clinical studies were performed on a very limited number of eyes from a nonrepresentative cohort and provided inconclusive results.[@b2-opth-7-1041],[@b3-opth-7-1041]

The VisuMax® Femtosecond System laser platform (Carl Zeiss Meditec AG, Jena, Germany) is the only commercially available femtosecond laser platform equipped to perform femtosecond lenticule extraction (FLEX) surgery. The procedure is called FLEX because it involves creating and then lifting a hinged femtosecond flap above the lenticule; if a flap is not created and the lenticule is extracted from a 3--4 mm side cut, the procedure is called a small-incision lenticule extraction (SMILE). Early refractive results using the VisuMax platform for SMILE and FLEX are encouraging.[@b4-opth-7-1041]--[@b9-opth-7-1041] However, Shah and Shah found that refractive results stabilized within the first week after surgery but that visual recovery was slower.[@b8-opth-7-1041] No detailed information is available in the literature regarding the amount of line loss at different follow-up periods. Moreover, there are no comparative studies between FLEX and femtosecond laser-assisted in situ keratomileusis (FemtoLASIK). In the current study, we describe refractive results, efficacy, and safety of the FLEX procedure compared with that of the FemtoLASIK procedure.

Materials and methods
=====================

Surgery was performed on both eyes of 14 consecutive patients with myopia or myopic astigmatism. Under the care of two surgeons, each patient underwent FLEX in one eye and FemtoLASIK in the contralateral eye. This prospective pilot study was approved by the hospital's Ethics Committee, and all patients provided informed consent.

Patients older than 18 years of age with myopia or myopic astigmatism were included in the study. Additional inclusion criteria were: spherical equivalent (SE) \<10 diopters (D), mesopic (4 lux) pupil size ≤ 6.5 mm, residual stromal bed thickness \> 300 μm, best corrected visual acuity of at least 20/25 in both eyes, no ocular disease other than the refractive error, a normal topographic pattern, regular retinoscopic reflex, corneal pachymetry \> 500 μm at the thinnest point, and stable refraction for at least 2 years.

All patients received the preoperative refractive surgical procedure routinely offered at the clinic. Visual acuity measurements were made using an illuminated ETDRS chart (Optec® 3500 Vision Tester; Stereo Optical Co, Santa Ana, CA, USA). Objective cycloplegic refraction was measured using an Auto Kerato-Refractometer KR-1 (Topcon Corp, Tokyo, Japan) with retinoscopy, in all patients. Corneal topography, dynamic infrared pupillography, ocular wavefront analysis, and corneal wavefront analysis were performed using the Sirius corneal topography and aberrometry system (Costruzioni Strumenti Oftalmici, Scandicci, Italy). Horizontal corneal diameter was measured using a IOLMaster 500 (Carl Zeiss Meditec). Intraocular pressure was measured with a Goldmann applanation tonometer (Haag streit Medical Products, Mason, Ohio, USA). All patients had detailed anterior and posterior segment examination using a slit lamp.

Immediately postsurgery, patients were evaluated with the slit lamp by the surgeon. Follow-up visits occurred at 1 week, 1 month, 3 months, and 6 months after the surgery. Objective and subjective refraction eye tests were performed, and uncorrected and best corrected distance visual acuities were recorded during all follow-up visits. Visual acuities were transformed to the logarithm of the minimum angle of resolution (LogMAR) prior to statistical analysis.

The VisuMax femtosecond laser platform was used for all the FLEX surgeries. This femtosecond laser platform creates four cleavage planes at a pulse repetition rate of 500 Hz. The spot distance used in this study was 3 μm for lamellar cuts and 2 μm for the side cuts. The spot energy was set to 140--150 nJ. The minimum lenticule side cut thickness was set to 15 μm, and the flap thickness was set to 110 μm. The lenticule side cut angle was 120°, and the flap side cut angle was 90°. The optical zone was 6.5 mm, and the flap diameter was 7.5 mm, with a 50° superior hinge in all patients. The optical zone diameter is equal to the lenticule diameter in patients with purely spherical refractive error. However, if the patient has astigmatism, the software adds a standard 0.1 mm transition zone to convert the oval lenticule into a circle.

The VisuMax femtosecond laser platform was used to create the flaps for all the FemtoLASIK patients. A flap diameter of 8.5 mm and thickness of 110 μm were intended. Excimer laser treatment was performed using the Amaris 750 s Excimer Laser platform (Schwind eye-tech-solutions GmbH and Co KG, Kleinostheim, Germany). All treatments were calculated using the ORK-CAM software module (Schwind eye-tech-solutions GmbH and Co KG). A 6.5 mm optical zone was used for ablation. A variable transition size, automatically provided by the laser, was used for the planned refractive correction in the myopic and myopic astigmatic eyes (6.7 mm to 8.6 mm). The laser works at a true repetition rate of 750 Hz and produces a beam size of 0.54 mm full-width at half-maximum, with super Gaussian spot profile.[@b10-opth-7-1041] High-speed eye tracking (pupil and limbus tracker with cyclotorsional tracking) with a 1050 Hz acquisition rate was completed within a latency time of 3 ms.[@b11-opth-7-1041],[@b12-opth-7-1041]

The FLEX procedure was performed first. After standard sterile draping of the eye, a speculum was inserted. The patient was asked to look at the internal fixation light while the surgeon, looking through the surgical microscope, adjusted the position of the eye in relation to the curved patient interface, using a joystick. Once the patient interface was centered on the pupil and a sufficient amount of contact was achieved, the surgeon activated the suction mechanism incorporated in the patient interface. Once the eye was immobilized, the delivery of the femtosecond laser pulses was initiated. The time from the beginning of the femtosecond laser pulses to the release of suction took approximately 30 seconds. After the femtosecond dissection planes were created, the patient bed was repositioned directly under the operating microscope for the rest of the surgery. A Katena Thorlakson Z-LASIK™ flap lifter (Katena Products Inc, Denville, NJ, USA) was used to separate the anterior surface of the lenticule from the overlying stroma and lift the flap. The lenticule was then separated from the underlying stroma using the same spatula, and it was removed manually with Katena Buratto LASIK Flap Forceps (Katena Products Inc). The stromal bed was washed with a balanced salt solution (Isolyte S®, Eczacıbaşı Baxter, Turkey), and the flap was repositioned.

For FemtoLASIK surgery, each procedure was performed using established standard techniques. Under topical anesthesia and standard draping, a lid speculum was used to retract the eyelids. A superior hinged, 110 μm-thick flap was created using the VisuMax femtosecond laser. The patient was then transported to the patient bed of the Amaris 750S excimer laser platform, and laser ablation was performed. After ablation, the flap was carefully repositioned. After surgery, all patients received a topical antibiotic for 5 days and a topical steroid for 2 weeks. Artificial tears were prescribed for at least 1 month.

All visual acuities were recorded as the total number of identified letters and the corresponding Snellen acuities. Mean visual acuities were determined by calculating the geometric mean with standard deviation, stated in LogMAR format as defined by Holladay and Prager.[@b13-opth-7-1041] Repeated measures analysis of variance (RANOVA) was used to compare visual acuities and SE of refractive results in each group at different follow-up visits. A *P*-value \< 0.05 was considered statistically significant. Paired samples *t*-test with a Bonferroni correction was used for post hoc analysis. Independent Samples *t*-test was used to compare the groups. All analyses were completed using PASW Statistics 18 (IBM, Armonk, NY, USA), and graphics were generated with Microsoft Excel 2007 (Microsoft Corp, Redmond, WA, USA)

Results
=======

The study enrolled 28 eyes of 14 consecutive patients. The mean age of the four men and ten women was 27.3 ± 7.9 years, ranging from 18 to 42 years of age. Refractive characteristics of the patients are summarized in [Table 1](#t1-opth-7-1041){ref-type="table"}. The baseline refractive characteristics were similar for both eyes in the patients ([Table 2](#t2-opth-7-1041){ref-type="table"}).

The mean SE was −0.37 ± 0.60 D (range −0.88 to 0.50) (*P* \< 0.001) and −0.25 ± 0.41 D (range −1.00 to 0.12 D) (*P* \< 0.001) in the FLEX and FemtoLASIK eyes, respectively. [Figure 1](#f1-opth-7-1041){ref-type="fig"} shows the scatterplot of the achieved refractive correction versus the intended refractive correction with a corresponding regression line, at 6 months. The SE was within ± 0.50 D of the intended correction in 86% of the FLEX eyes, and in 100% within ± 1.00 D. The intended correction was achieved in 12 eyes in the FLEX group, and 13 eyes in the FemtoLASIK group ([Figure 2](#f2-opth-7-1041){ref-type="fig"}). The preoperative and postoperative refractive astigmatism of the patients are shown in [Table 3](#t3-opth-7-1041){ref-type="table"}. The stability of the refractive correction did not change after the 3 months, in both groups ([Figure 3](#f3-opth-7-1041){ref-type="fig"}).

The mean differences between the intended and achieved corrections were not statistically significant between groups at any of the follow-up visits (*P* \> 0.05) ([Table 4](#t4-opth-7-1041){ref-type="table"}). The differences of the mean uncorrected distance visual acuity (UDVA) between groups at follow-up visits were also not statistically significant (*P* \> 0.05) ([Table 5](#t5-opth-7-1041){ref-type="table"}).

Four eyes (29%) lost one line, while one eye (7%) lost two lines of corrected distance visual acuity (CDVA) at week one in the FLEX group. Seven eyes (50%) lost one line, while one eye (7%) lost two lines of CDVA at week 1, in the FemtoLASIK group. However, at 1 month, 3 months, and 6 months postsurgery, no eye had lost one or more lines of CDVA ([Figure 4](#f4-opth-7-1041){ref-type="fig"}).

Discussion
==========

Two excimer laser-based refractive surgery modalities are now in widespread use: LASIK and photorefractive keratectomy (PRK).[@b14-opth-7-1041],[@b15-opth-7-1041] Between these, LASIK is the more popular, mainly because of faster visual rehabilitation and a more comfortable postoperative period.[@b14-opth-7-1041] FLEX has recently become an alternative procedure.[@b4-opth-7-1041],[@b5-opth-7-1041] FLEX is based on the same concept as LASIK, which involves removal of a refractive lenticule from corneal stroma. In LASIK, the lenticule is photoablated spot by spot with the excimer laser. However, in lenticule extraction, the lenticule is separated from the remaining stroma with photodisruption planes and removed manually as a single piece. With the excimer laser platforms, it is not possible to photoablate the intrastromal lenticule without lifting the anterior stromal tissue as a flap.

FLEX is a very straightforward procedure, with essentially no learning curve for a surgeon who is familiar with FemtoLASIK surgery. Sekundo et al[@b4-opth-7-1041] reported the first results of FLEX using the VisuMax platform. They operated on ten eyes of ten patients, but only 40% of the eyes were within ± 0.50 D of the intended correction (90% were within ± 1.00 D). In a larger series of patients published in 2010, Blum et al[@b5-opth-7-1041] also reported better results. They reported that 74% of patients were within ± 0.50 D. Since a prototype of the device and different energy settings were used in those two studies, their results cannot be directly compared with the current study results, which were significantly better. We used the latest generation of the VisuMax platform, with a 500 kHz spot repetition rate, 3 μm spot distance, and 140 nJ spot energy.

Results from studies by Shah and Shah,[@b8-opth-7-1041] and Ang et al[@b9-opth-7-1041] are consistent with those of the present study. They used a spot energy of approximately 160 nJ and reported that 95% of their patients were within ± 0.50 D of the intended correction at 6 months (when the current recommended scanning trajectory of the VisuMax platform was used). They observed that refractive results stabilized within the first week but that visual recovery was slower.

There is no detailed information in the literature regarding the amount of line loss that occurs at different follow-up periods. Only Shah and colleagues have reported the percentage of patients who lost two or more lines during the early postoperative period.[@b8-opth-7-1041] They reported that 5% of patients had lost two or more lines at 1 week postsurgery but that no patients lost two or more lines after 6 months. At 1 week postsurgery, 35% of patients in the FLEX group had a loss of two or more lines of CDVA. However, none of the patients had loss of two or more lines of CDVA at the 1-month, 3-month, and 6-month visits, and FLEX may be considered safe in this regard.

No statistically significant differences were observed in terms of achieved refractive correction after 1 week and 1 month. However, the mean UDVA was significantly worse at 1 week postsurgery. At 1 month, 95% of patients had UDVA ≥ 20/25, which was a considerable improvement from the 65% of patients with UDVA ≥ 20/25 at 1 week. The presence of worse UDVA despite the same amount of achieved refractive correction suggests that the visual acuity was delayed despite the successful refractive correction. This incompatibility was not observed in the FemtoLASIK group. Comparisons of achieved correction after 1 week and later visits were not statistically significant. Compatible with the statistically insignificant refractive difference, the UDVA were also similar (*P* \< 0.05).

Despite the slightly delayed visual recovery in the FLEX eyes, the refractive results and final visual acuities were similar in both groups. In the FLEX group, the SE was within ± 0.50 D of the intended correction, in 86% of eyes, and it was within ± 1.00 D of the intended correction, in all the eyes. Some studies have reported \> 95% of myopic patients to be within ± 0.50 D of the intended correction after LASIK surgery; however, the results vary greatly depending on patient selection and the excimer laser platform.[@b16-opth-7-1041] Contrary to other published studies,[@b4-opth-7-1041]--[@b9-opth-7-1041] there was a slight tendency for undercorrection, and none of the cases were found to be overcorrected. This difference may be due to differences in preoperative refractive errors, since the current study included eyes with the lowest preoperative SE, while previous studies did not.[@b4-opth-7-1041]--[@b9-opth-7-1041]

With respect to intraoperative complications, no suction loss or development of an excessive opaque bubble layer were noted. However, drying of the corneal epithelial surface during the actual surgical procedure greatly reduced the quality of the stromal cuts. No significant postoperative complications occurred in any case.

In conclusion, this study shows that FLEX is a safe and effective alternative to LASIK. The refractive results are comparable between both procedures; however, visual recovery is slightly slower after the FLEX procedure. The quality of stromal cuts was adequate for dissecting and removing the lenticule. Future optimization of laser energy, spot size, and spacing will potentially further simplify the removal of the lenticule and speed up visual recovery.
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![Scatterplot of the achieved refractive correction versus intended refractive correction.\
**Abbreviations:** FLEX, femtosecond lenticule extraction; LASIK, laser-assisted in situ keratomileusis; D, diopters.](opth-7-1041Fig1){#f1-opth-7-1041}

![Difference between achieved correction and intended correction at 6 months postsurgery.\
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![Stability of the spherical equivalent of subjective manifest refraction.\
**Abbreviations:** FLEX, femtosecond lenticule extraction; FemtoLASIK, femtosecond laser-assisted in situ keratomileusis; SE, spherical equivalent; D, diopters.](opth-7-1041Fig3){#f3-opth-7-1041}

![Change in Snellen lines of corrected distance visual acuity over time.\
**Abbreviations:** FLEX, femtosecond lenticule extraction; FemtoLASIK, femtosecond laser-assisted in situ keratomileusis](opth-7-1041Fig4){#f4-opth-7-1041}

###### 

Preoperative refractive characteristics of the patients

                                                           FLEX           FemtoLASIK                      
  -------------------------------------------------------- -------------- ---------------- -------------- ----------------
  Sphere[\*](#tfn1-opth-7-1041){ref-type="table-fn"}       −4.26 ± 1.52   −1.00 to −5.75   −4.01 ± 1.71   −1.00 to −6.75
  Cylinder[\*\*](#tfn2-opth-7-1041){ref-type="table-fn"}   −0.94 ± 1.12   0.00 to −3.00    −1.14 ± 0.96   0.00 to −2.75
  SE[\*\*\*](#tfn3-opth-7-1041){ref-type="table-fn"}       −4.74 ± 1.60   −1.75 to −6.75   −4.58 ± 1.49   −1.50 to −7.00
  Mesopic pupil diameter (mm)                              5.84 ± 0.78    4.96 to 6.45     5.32 ± 0.80    4.36 to 6.50

**Notes:**

Spherical component of the manifest refraction in the negative cylinder notation;

cylindrical component of the manifest refraction in the negative cylinder notation;

spherical equivalent of the manifest refraction.

**Abbreviations:** FLEX, femtosecond lenticule extraction; FemtoLASIK, femtosecond laser-assisted in situ keratomileusis; SD, standard deviation; SE, spherical equivalent.

###### 

Preoperative refractive characteristics of right and left eyes

                                                           Right          Left                            
  -------------------------------------------------------- -------------- ---------------- -------------- ----------------
  Sphere[\*](#tfn5-opth-7-1041){ref-type="table-fn"}       −4.21 ± 1.52   −1.00 to −6.75   −4.11 ± 1.74   −1.00 to −6.00
  Cylinder[\*\*](#tfn6-opth-7-1041){ref-type="table-fn"}   −1.05 ± 1.07   0.00 to −3.00    −1.03 ± 1.02   0.00 to −2.75
  SE[\*\*\*](#tfn7-opth-7-1041){ref-type="table-fn"}       −4.67 ± 1.57   −1.88 to −7.00   −4.57 ± 1.51   −1.50 to −6.50
  Mesopic pupil diameter (mm)                              5.39 ± 0.78    4.36 to 6.35     5.42 ± 0.83    4.66 to 6.50

**Notes:**

Spherical component of the manifest refraction in the negative cylinder notation;

cylindrical component of the manifest refraction in the negative cyclinder notation;

spherical equivalent of the manifest refraction.

**Abbreviations:** SD, standard deviation; SE, spherical equivalent.

###### 

Mean uncorrected distance visual acuities

  Follow-up visit   Mean cylindrical values   
  ----------------- ------------------------- --------------
  Preoperative      −0.94 ± 1.12              −1.14 ± 0.96
  Week 1            −0.37 ± 0.38              −0.35 ± 0.37
  Month 1           −0.32 ± 0.40              −0.28 ± 0.35
  Month 3           −0.30 ± 0.36              −0.26 ± 0.33
  Month 6           −0.35 ± 0.40              −0.32 ± 0.34

**Abbreviations:** FLEX, femtosecond lenticule extraction; FemtoLASIK, femtosecond laser-assisted in situ keratomileusis.

###### 

The mean of the differences between intended and achieved corrections

  Follow up visit   The mean of the difference[\*](#tfn10-opth-7-1041){ref-type="table-fn"} (D)   *P*-value      
  ----------------- ----------------------------------------------------------------------------- -------------- -------
  Week 1            −0.24 ± 0.27                                                                  −0.14 ± 0.39   0.411
  Month 1           −0.31 ± 0.32                                                                  −0.29 ± 0.31   0.888
  Month 3           −0.31 ± 0.36                                                                  −0.28 ± 0.32   0.791
  Month 6           −0.29 ± 0.30                                                                  −0.25 ± 0.30   0.594

**Notes:**

Achieved correction -- intended correction

**Abbreviations:** FLEX, femtosecond lenticule extraction; FemtoLASIK, femtosecond laser-assisted in situ keratomileusis; D, diopters.

###### 

Mean uncorrected distance visual acuity (UDVA)

  Follow up visit   Mean UDVA (LogMAR ± SD)   *P*-value     
  ----------------- ------------------------- ------------- -------
  Preoperative      1.32 ± 0.40               1.39 ± 0.40   0.660
  Week 1            0.22 ± 0.23               0.19 ± 0.20   0.699
  Month 1           0.20 ± 0.25               0.11 ± 0.14   0.242
  Month 3           0.15 ± 0.20               0.09 ± 0.13   0.314
  Month 6           0.02 ± 0.03               0.02 ± 0.04   0.704

**Notes:** The differences between the groups at month 1, month 3, and month 6 were not statistically significant.

**Abbreviations:** FLEX, femtosecond lenticule extraction; FemtoLASIK, femtosecond laser-assisted in situ keratomileusis; LogMAR, logarithm of the minimum angle of resolution; SD, standard deviation.
